Page last updated: 2024-08-22

sulfadoxine and Glycogen Storage Disease Type I

sulfadoxine has been researched along with Glycogen Storage Disease Type I in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Enevold, A	1

Other Studies

1 other study(ies) available for sulfadoxine and Glycogen Storage Disease Type I

Article	Year
The influence of genetic innate resistance and acquired immunity on drug treatment outcome of uncomplicated Plasmodium falciparum malaria in Tanzania. Parassitologia, 2006, Volume: 48, Issue:4 Topics: Animals; Antimalarials; Awards and Prizes; Child, Preschool; Comorbidity; Cross-Sectional Studies; Drug Combinations; Drug Resistance; Endemic Diseases; Genetic Predisposition to Disease; Genetic Testing; Glucosephosphate Dehydrogenase; Glycogen Storage Disease Type I; Hemoglobinopathies; Hemoglobins, Abnormal; Humans; Immunity, Innate; Infant; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tanzania; Treatment Outcome	2006

Article

Year

The influence of genetic innate resistance and acquired immunity on drug treatment outcome of uncomplicated Plasmodium falciparum malaria in Tanzania.

Parassitologia, 2006, Volume: 48, Issue:4

Topics: Animals; Antimalarials; Awards and Prizes; Child, Preschool; Comorbidity; Cross-Sectional Studies; Drug Combinations; Drug Resistance; Endemic Diseases; Genetic Predisposition to Disease; Genetic Testing; Glucosephosphate Dehydrogenase; Glycogen Storage Disease Type I; Hemoglobinopathies; Hemoglobins, Abnormal; Humans; Immunity, Innate; Infant; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tanzania; Treatment Outcome

2006